-
Signature
-
/s/ Ewelina Kemp, Attorney-in-Fact for Rifat Kerim Akgonul
-
Issuer symbol
-
PEGA
-
Transactions as of
-
01 Sep 2025
-
Net transactions value
-
-$420,191
-
Form type
-
4
-
Filing time
-
04 Sep 2025, 16:49:39 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Akgonul Rifat Kerim |
Chief Product Officer |
C/O PEGASYSTEMS INC., 225 WYMAN STREET, STE 300, WALTHAM |
/s/ Ewelina Kemp, Attorney-in-Fact for Rifat Kerim Akgonul |
04 Sep 2025 |
0001855325 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PEGA |
Common stock |
Options Exercise |
$0 |
+1,176 |
+1.5% |
$0.000000 |
79,736 |
01 Sep 2025 |
Direct |
F1 |
| transaction |
PEGA |
Common stock |
Tax liability |
$30,845 |
-569 |
-0.71% |
$54.21 |
79,167 |
01 Sep 2025 |
Direct |
|
| transaction |
PEGA |
Common stock |
Options Exercise |
$0 |
+462 |
+0.58% |
$0.000000 |
79,629 |
02 Sep 2025 |
Direct |
F2 |
| transaction |
PEGA |
Common stock |
Tax liability |
$12,143 |
-224 |
-0.28% |
$54.21 |
79,405 |
02 Sep 2025 |
Direct |
|
| transaction |
PEGA |
Common stock |
Sale |
$101,384 |
-1,900 |
-2.4% |
$53.36 |
77,505 |
02 Sep 2025 |
Direct |
F3, F4 |
| transaction |
PEGA |
Common stock |
Sale |
$5,418 |
-100 |
-0.13% |
$54.18 |
77,405 |
02 Sep 2025 |
Direct |
F3 |
| transaction |
PEGA |
Common stock |
Sale |
$270,400 |
-5,000 |
-6.5% |
$54.08 |
72,405 |
03 Sep 2025 |
Direct |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PEGA |
Restricted Stock Units |
Options Exercise |
$0 |
-1,176 |
-14% |
$0.000000 |
7,052 |
01 Sep 2025 |
Common stock |
1,176 |
$0.000000 |
Direct |
F1, F6, F7 |
| transaction |
PEGA |
Restricted Stock Units |
Options Exercise |
$0 |
-462 |
-33% |
$0.000000 |
922 |
02 Sep 2025 |
Common stock |
462 |
$0.000000 |
Direct |
F2, F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: